Quality, Standards & Compliance
|2 min read
A2LA’s New Mission and Vision Focus on Global Health and Safety
The organization updated its mission and vision for the first time in eight years to highlight its impact and expertise
|2 min read
AI-Based Personalized Therapies Need Agile Approval Processes
Commercializing AI-based treatment warrants regulatory changes and multilayered testing and monitoring approaches
|3 min read
Easing the Burden of Biotherapeutic Characterization Method Transfers
Attention to consistency is pivotal to transferring and optimizing characterization methods
Updated |2 min read
WHO Extends Deadline for Trans People Health Guideline Feedback
The WHO aims to improve trans and gender-diverse people’s access to quality health care
|2 min read
CMS Update Raises Standards for Clinical Laboratories under CLIA
Effective January 28, the updated rules address recent questions around nursing degree equivalency and the status of DCLS professionals
Updated |2 min read
Factors to Consider When Using Enzyme Verification Materials in Clinical Research
Calibrated and validated clinical reference materials are the cornerstone of enzyme analyses
|2 min read
Genetic Priority Score Finetunes Drug Development
Innovative approach integrates genetic data to identify drug targets with high potential for clinical trial success
|1 min read
From Financial Loss to Profitable Practice: A Success Story
Learn how a vision for better health care informed MGUH’s transformation
|2 min read
WHO to Develop A Guideline for Trans and Gender-Diverse People’s Health
New guideline will provide interventions to increase access and equitable utilization of quality health services
|3 min read
Null Hypothesis Significance Testing May Be an Inaccurate Tool
New study suggests looking beyond NHST and P values when triaging statistical data and findings
|2 min read
The Impact of Suboptimal Cancer Drug Trials on Patient Health
About 60 of 400 Phase 2 and 3 cancer drug trials registered between 2016 and 2017 had suboptimal control arms
|2 min read
Our Top Stories of 2023
A roundup of this year's advances in cancer research, compliance, automation, lab management, and more!
